PCG Wealth Advisors LLC Sells 112 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

PCG Wealth Advisors LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 19.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 462 shares of the healthcare conglomerate’s stock after selling 112 shares during the quarter. PCG Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $237,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. GSA Capital Partners LLP purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $642,000. Rowland & Co. Investment Counsel ADV purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $169,000. Unigestion Holding SA raised its holdings in shares of UnitedHealth Group by 25.9% in the 4th quarter. Unigestion Holding SA now owns 4,786 shares of the healthcare conglomerate’s stock valued at $2,403,000 after acquiring an additional 986 shares in the last quarter. IHT Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 9.9% during the 4th quarter. IHT Wealth Management LLC now owns 3,837 shares of the healthcare conglomerate’s stock valued at $1,927,000 after buying an additional 345 shares in the last quarter. Finally, Banco de Sabadell S.A raised its holdings in shares of UnitedHealth Group by 43.1% during the 4th quarter. Banco de Sabadell S.A now owns 10,402 shares of the healthcare conglomerate’s stock valued at $5,235,000 after buying an additional 3,132 shares in the last quarter. Institutional investors own 87.25% of the company’s stock.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the transaction, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Andrew Witty sold 11,376 shares of the company’s stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now owns 76,559 shares in the company, valued at $40,415,496.10. The disclosure for this sale can be found here. Insiders sold 139,051 shares of company stock valued at $74,450,958 over the last 90 days. Company insiders own 0.40% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. Mizuho raised their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, August 10th. BMO Capital Markets raised their price target on UnitedHealth Group from $600.00 to $610.00 in a research report on Wednesday, July 20th. SVB Leerink raised their price target on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Credit Suisse Group raised their price target on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Finally, UBS Group raised their price target on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research report on Thursday, July 21st. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $586.40.

UnitedHealth Group Trading Up 1.1 %

NYSE UNH opened at $517.46 on Friday. The stock’s 50 day moving average is $530.11 and its 200 day moving average is $512.45. The firm has a market capitalization of $484.02 billion, a PE ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. During the same quarter in the previous year, the business earned $4.70 earnings per share. The firm’s quarterly revenue was up 12.6% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were paid a $1.65 dividend. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.